GenOMICC study on COVID-19 patients

If you have had COVID-19 and would like to register your interest in taking part in this study, please click the button below.

Please only register your interest if you are 16 years old or above and resident in the UK.

 Register now 

Genomics England, in partnership with the GenOMICC consortium, is working with the NHS to deliver whole genome sequencing of up to 20,000 people who have been severely affected by COVID-19 – requiring intensive care – and 15,000 people who had mild symptoms.

This study aims to find out whether there are genetic factors that mean that some people experience severe symptoms whilst others experience only mild symptoms.

See our full press release, or register your interest to take part in this study.

If you register your interest, we will use the information you submit to help us identify if you are eligible for the study and ensure that the study is representative. If you are eligible, we will get in touch with more information so that you can decide if you still wish to take part.

COVID-19’s impact on the 100,000 Genomes Project

Although many participants will have received a result at this stage, we are aware that there are still some participants who have not received anything yet. We have also promised to do reanalysis for all 100,000 Genomes Project participants, and additional findings for those who have asked for them. Unfortunately, this work is now being delayed due to our focus on COVID-19. Genomics England and NHS England have jointly written a letter to participants, which you can download below.

Download the letter here